The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and OAD Therapy

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 438 participants.

Also called NCT01676116

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 438 participants (enrolled count) (from the registry)
Sponsor
  • Novo Nordisk Registry lists this organization as the lead sponsor
Registry
  • NCT NCT01676116
  • EudraCT 2012-000209-63
Other papers using this trial's data
  • EFFICACY AND SAFETY OF IDEGLIRA IN OLDER PATIENTS WITH TYPE 2 DIABETES Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2019-02 DOI, PubMed 30383495

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Australia, France, Hungary, Slovakia (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01676116. Randomized; no masking; primary purpose treatment. Start 2012-08-29 (actual); primary completion 2014-03-11 (actual). Results posted on 2018-07-09.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and OAD Therapy
Acronym
DUAL™ III
Condition
Diabetes
Condition
Diabetes Mellitus, Type 2
Intervention (Drug)
insulin degludec/liraglutide
Intervention (Drug)
liraglutide
Intervention (Drug)
exenatide
Lead sponsor
Novo Nordisk A/S (class: industry)

Record details

Record id
cardio:ct-nct01676116
Content hash
1a73e75b14ce494fb96cc7796cd7997c17ed9677ffcc4d8998aca1806f2044f3